University of Exeter Featured PhD Programmes
University of Dundee Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Exeter Featured PhD Programmes
The University of Manchester Featured PhD Programmes

Cancer / Oncology (cell culture) PhD Projects, Programs & Scholarships

We have 108 Cancer / Oncology (cell culture) PhD Projects, Programs & Scholarships

  • "cell" AND "culture" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 21 to 30 of 108
  Investigating the requirements of pro-inflammatory signaling in skin and head & neck Squamous Cell Carcinomas
  Dr C Darido
Applications accepted all year round

Funding Type

PhD Type

Squamous cell carcinomas (SCC) are amongst the most common cancer types afflicting man. SCCs most frequently arise from stratified squamous epithelia such as the epidermis or the mucosae of the head and neck.
  Therapeutic opportunities in mutant p53 cancer cells
  Dr P Muller
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Dr Patricia Muller’s research group is based at the Cancer Research UK Manchester Institute, Alderley Park, Cheshire.
  Clinically relevant mini-organs to identify optimal “chemo”-free treatments for childhood cancer Phase I trials (ref: RDF20/APP/PAL)
  Dr D Pal
Application Deadline: 24 January 2020

Funding Type

PhD Type

Better cancer therapeutics are urgently needed to maximise patient outcome. Cancer drug development is associated with the highest attrition rates thereby underscoring the immediate requirement for improved preclinical models.
  Preparing the acid bath: how epidermal growth factor receptor (EGFR) controls its own down-regulation
  Prof P Woodman, Dr C Francavilla
Applications accepted all year round

Funding Type

PhD Type

Signalling by cell surface receptors determines nearly every aspect of the cell’s response to its environment. Endosomes are hubs for regulating these signalling pathways.
  Precision Medicine DTP - Proteomic analysis of FAK function in human pancreatic cancer
  Research Group: Centre for Inflammation Research
  Dr A Serrels, Dr A Byron, Dr A von Kriegsheim
Application Deadline: 8 January 2020

Funding Type

PhD Type

Background. In the United Kingdom, the 5-year survival rate for patients with pancreatic ductal adenocarcinoma (PDAC) is just 3% (Cancer Research UK statistics), and as a result pancreatic cancer is the 4th most common cause of cancer death in the UK and US.
  Characterisation of the role of the adhesion protein tensin 3 in breast cancer progression
  Dr E Rainero
Applications accepted all year round

Funding Type

PhD Type

Breast cancer arises from the transformation of mammary epithelial cells. In the healthy tissue, these grow as a single monolayer of cells delimiting an internal hollow lumen 2.
  Homeostatic mechanisms in human urothelium: balancing of tissue regeneration and differentiation with implications for regenerative medicine and cancer
  Prof J Southgate
Application Deadline: 30 June 2020

Funding Type

PhD Type

The urothelium is the self-regenerating epithelium that lines the bladder, where it is highly specialised to function as a urinary barrier.
  MRC DiMeN Doctoral Training Partnership: Investigating the mechanisms leading to CHK1 inhibitor resistance in cancer therapy
  Prof N Perkins, Prof S Rocha, Dr J Hunter
Application Deadline: 6 January 2020

Funding Type

PhD Type

DNA replication stress results from stalled DNA replication forks and is a feature of cancer cells, where it can lead to the genomic instability driving tumorigenesis.
  The role of the breast microenvironment in suppressing early cancer invasion
  Assoc Prof B Parker, Dr D Zanker
Applications accepted all year round

Funding Type

PhD Type

Ductal carcinoma in situ (DCIS) is a pre-invasive stage of breast cancer, whereby the tumour cells remain restrained by myoepithelial cells that surround breast ducts.
  Exploiting tumour-promoting paracrine signals in solid cancers to turbocharge genetically redirected T cells
  Dr A Hurlstone, Prof R Edmondson
Applications accepted all year round

Funding Type

PhD Type

Adoptive cell therapy (ACT) using tumour infiltrating lymphocytes (TILs) or genetically redirected T cells are some of the most promising approaches to emerge recently for the treatment of metastatic disease.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.